Kingdon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-57,603
Closed -$15.8M 83
2019
Q1
$15.8M Buy
+57,603
New +$14.3M 2.11% 19
2018
Q4
Sell
-36,824
Closed -$8.99M 96
2018
Q3
$8.99M Sell
36,824
-6,916
-16% -$1.59M 0.63% 61
2018
Q2
$9.06M Sell
43,740
-29,522
-40% -$6.27M 0.63% 59
2018
Q1
$15.1M Buy
73,262
+30,031
+69% +$6.3M 1.2% 25
2017
Q4
$8.21M Buy
+43,231
New +$8.28M 0.53% 60

Other funds holding TMO

Kingdon Capital Management's TMO Position: Q2 2019 in Review

Kingdon Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2019, closing a stake of 57,603 shares — an estimated $15.8M sold.

Kingdon Capital Management first reported a position in TMO in Q4 2017 and held it in 5 quarters. The position peaked at $15.8M in Q1 2019. 1,559 funds tracked by Wall St. Rank hold TMO as of Q2 2019.

  • Kingdon Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2019 after selling out during the quarter.
  • Kingdon Capital Management sold 57,603 Thermo Fisher Scientific shares in Q2 2019, an estimated $15.8M.
  • Kingdon Capital Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 5 quarters.
  • Kingdon Capital Management's Thermo Fisher Scientific position peaked at $15.8M in Q1 2019.
  • 1,559 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2019.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.